drugset / Trial / NCT06375187
A Study of GC203 TIL in Advanced Malignant Solid Tumors
NaSingle-groupOpen-labelTreatment
Summary
A clinical trial to assess the safety and efficacy of engineered Tumor Infiltrating Lymphocytes (TIL) for the treatment of Advanced Malignant Solid Tumors
Timeline
- Start
- 2024-05-29
- Primary completion
- 2026-11-01
- Completion
- 2027-05-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Engineering Tumor Infiltrating Lymphocytes | Cell therapy | — | — |